T. Dolinay (Chattanooga, United States of America), J. Hamacher (Bern, Switzerland)
The loss of pulmonary barrier function as a result of application of anticancer agents paclitaxel, 2-methoxyestradiol, and their combination
N. Bogatcheva, B. Gorshkov, M. Zemskova, A. Verin (Augusta, United States Of America)
|   |
Protective effects of keratinocyte growth factor-2 on lipopolysacchride-induced acute lung injury
L. Tong, J. Bi, Y. Song, X. Wang, X. An, C. Bai (Shanghai, China; San Francisco, United States Of America)
| |
Creatine supplementation inhibits acute lung injury induced by pulmonary ischemia-reperfusion
F. Maria de Almeida, R. Pazetti, F. D. T. Q. S. Lopes, S. Fátima Soto, M. de Arruda Martins, M. Dolhnikoff, R. de Paula Vieira (Sao Paulo, Brazil; , Germany)
| |
Effects of aerobic exercise in LPS-induced acute lung injury
C. Tokio Reis Gonçalves, C. G. Reis Gonçalves, F. Maria Almeida, F. D. T. Q. S. Lopes, M. Arruda Martins, H. C. Castro-Faria-Neto, R. Paula Vieira, M. Dolhnikoff (Sao Paulo, Rio de Janeiro, Brazil; , Germany)
| |
Phenotipic diferences between alveolar and interstitial macrophages in acute lung injury induced by pancreatitis
S. Gea-Sorlí, A. Serrano-Mollar, O. Bulbena, D. Closa (Barcelona, Spain)
| |
Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome
Y. Tan, W. Han, Y. Chen, D. Ma, N. Zhong (Guangzhou, Beijing, China)
| |
Characterization of alveolar injury attributable to high-stretch ventilation
V. Egido, A. López-Sánchez, L. Martínez-Caro, J. A. Lorente, P. Fernández-Segoviano, A. Esteban, C. Casals (Madrid, Spain)
| |
Does high amplitude mechanical stretch influence toll like receptor 4 (TLR4) expression and signaling?
S. Hammerschmidt, K. Walter, H. Kuhn, H. J. Seyfarth, C. Gessner, H. Wirtz (Leipzig, Germany)
| |
Local and systemic pathophysiological differences in a model of pulmonary and extra pulmonary ALI submitted to mechanical ventilation with PEEP
E. Yoshioka, F. Arantes-Costa, D. Barbeiro, H. Barbeiro, J. Segarra, A. C. Daldosso, E. Negri (Brazil)
| |
Positive- versus negative-pressure ventilation in healthy rats
M. Pecchiari, A. Koutsoukou, P. Della Valle, G. Gentile, A. Monaco, E. D‘Angelo (Milan, Italy; Athens, Greece)
| |
Temporal changes in gene expressions and cytokine productions caused by stretching of normal human pulmonary artery endothelial cells
K. Kobayashi, M. Tanaka, H. Inaoka, S. Nebuya, Y. Fukuoka, K. Kokubo, H. Kobayashi, M. Noshiro (Sagamihara, Bunkyou-ku, Japan)
| |
Response of human lung fibroblasts to LPS: Cytokine production and cellular proliferation
J. Zhang, J. Qu, L. Wu (Shanghai, China; Auckland, New Zealand)
| |
Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
M. Kontogiorgi, V. Kalodimou, G. Agrogiannis, E. Patsouris, A. Papalois (Pikermi, Amarousion, Athens, Greece)
| |
Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway
K. Kuronuma, K. Kudo, Y. Kuroki, H. Takahashi (Japan)
| |
Effects of Liver X receptor agonist treatment on signal transduction pathways in acute lung inflammation
E. Esposito, E. Mazzon, I. Paterniti, M. Galuppo, P. Bramanti, S. Cuzzocrea (Messina, Italy)
| |
Apelin attenuates neonatal hyperoxic lung and heart injury in a rat model of bronchopulmonary dysplasia
G. Wagenaar, Y. de Visser, E. H. Laghmani, A. van der Laarse, F. Walther (Netherlands)
| |
The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse
Y. H. Kim, J. W. Kim, J. S. Kim, C. K. Park, S. S. Kwon, J. H. Ahn, K. H. Park, C. H. Kim (Seoul, Republic Of Korea)
| |
The deglycosylated form of bleomycin induces minor lung toxicity
G. Wettstein, N. Decologne, P. S. Bellaye, C. Garrido, A. Bettaieb, P. Camus, P. Bonniaud (Dijon, France)
| |
The role of peroxyredoxines in respiratory tract during oxidative stress processes
V. Novoselov, E. Mubarakshina, S. Soodaeva, I. Klimanov, A. Lisitsa (Moscow Region, Moscow, Russian Federation)
| |